Tacrolimus therapy for refractory renal allograft rejection: experience with steroid withdrawal

Transplant Proc. 1997 Feb-Mar;29(1-2):307. doi: 10.1016/s0041-1345(96)00273-4.

Authors

D C Cronin 2nd¹, D S Bruce, K A Newell, M A Josephson, J M Millis, J B Piper, M Ruebe, M Kirby, J R Thistlethwaite Jr, E S Woodle

Affiliation

¹ Department of Surgery, University of Chicago, IL 60637, USA.

PMID: 9123010
DOI: 10.1016/s0041-1345(96)00273-4

No abstract available

MeSH terms

Adult
Antilymphocyte Serum / therapeutic use
Creatinine / blood
Drug Therapy, Combination
Follow-Up Studies
Graft Rejection / drug therapy*
Graft Rejection / pathology
Humans
Immunosuppressive Agents / therapeutic use*
Kidney Transplantation / immunology*
Kidney Transplantation / pathology
Kidney Transplantation / physiology
Muromonab-CD3 / therapeutic use
Prednisone / therapeutic use
Tacrolimus / therapeutic use*
Time Factors
Transplantation, Homologous

Substances

Antilymphocyte Serum
Immunosuppressive Agents
Muromonab-CD3
Creatinine
Prednisone
Tacrolimus